RET, ROS1 and ALK fusions in lung cancer-Reference-Cited by-同舟云学术

RET, ROS1 and ALK fusions in lung cancer

Published:2012-02-12 Issue:3 Volume:18 Page:378-381
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Takeuchi Kengo,Soda Manabu,Togashi Yuki,Suzuki Ritsuro,Sakata Seiji,Hatano Satoko,Asaka Reimi,Hamanaka Wakako,Ninomiya Hironori,Uehara Hirofumi,Lim Choi Young,Satoh Yukitoshi,Okumura Sakae,Nakagawa Ken,Mano Hiroyuki,Ishikawa Yuichi

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/nm.2658.pdf

Reference20 articles.

1. Soda, M. et al. Nature 448, 561–566 (2007).

2. Takeuchi, K. et al. Clin. Cancer Res. 14, 6618–6624 (2008).

3. Takeuchi, K. et al. Clin. Cancer Res. 15, 3143–3149 (2009).

4. Rikova, K. et al. Cell 131, 1190–1203 (2007).

5. Takeuchi, K. et al. Haematologica 96, 464–467 (2011).

Cited by 1155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals;Current Problems in Cancer;2024-12

2. Revisiting ALK (D5F3) immunohistochemistry: Insights into focal staining and neuroendocrine differentiation;Thoracic Cancer;2024-09-10

3. Genomic instability in congenital lung malformations in children;Pediatric Surgery International;2024-09-05

4. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

5. Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”;Cancers;2024-08-19